Rezultati pretraživanja
  1. 13. ožu 2018.

    The 2018 from is now published, packed with facts, statistics and analysis to give you insight into the state of pharma R&D today, with a musical twist this year. Download your free copy at

  2. 6. stu 2014.

    GSK's mepolizumab trials=1st anti-IL5 biologic filed for approval. Check out top competitors

  3. 11. tra 2018.

    The 2018 reporting on 2017's new drug launches and related trends is now available as a free download from . Click here to get your copy!

  4. 23. velj 2016.

    These days there is no abundance of spare time and money to easily handle : you need be much more efficient than before.

  5. 22. kol 2014.
  6. 3. lis 2014.

    Congrats to my colleagues Tom Stirzaker & Igor Saposhnikov for their IBI Content Award for Trends!

  7. 21. stu 2016.
  8. 12. kol 2014.

    Who are your industry competitors - tweet for a FREE demonstration

  9. 12. kol 2014.

    tweet - i will give you a free PERSONALIZED demonstration to analyze your competitive landscape!

  10. 7. tra 2014.

    How did 2013 stack up for new active substance drug launches? Great summary by

  11. 14. ožu 2018.

    Who were Pharma's rock stars in 2017? Find out in Pharma Intelligence's latest Annual Pharma R&D review.

  12. 19. ožu 2019.

    Discover , the powerful drug development intelligence you can rely on. Download the info flyer here

  13. 7. svi 2019.

    Click to read about how Novartis & J&J are backing technologies that could transform the human body into a disease-destroying machine. Data from via

  14. exploding. shows the trend over past 5 yrs in . Over 400 on the market.

  15. 20. ožu 2019.

    The Pharma R&D Annual Review 2019 is based on the stats and data from & our whitepaper contains the whole 9 yards. Download your copy here today

  16. 29. tra 2019.

    Our essential whitepaper uses critical data from to examine the new entities that were successfully launched to market last year. Click to download your free copy here:

  17. 20. srp 2015.

    confidence appears high after record year analysis

  18. 23. ruj 2014.

    's unique data set of trends in is analyzed in a new report at

  19. Remember the epidemic in West Africa? Infoma Group Citeline offers a review of Ebola R&D

  20. 12. tra 2017.

    The New Active Substances supplement to the 2017 from is coming soon! Only 41 NASs were launched in 2016.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.